NCT05744622

Brief Summary

Introduction: Glass ionomer cements (GICs) are widely used in clinical dentistry due to their advantageous properties. However, they present inferior physical and mechanical properties compared to resin composites. Aim: Clinical evaluation of chemically cured conventional glass ionomer after light-emitting diode radiant heat enhancement. . Methodology: Eighteen healthy patients with 36-second molar teeth will be selected where each patient should have two oclusso- mesial cavities. Standardized oclusso- mesial cavities will be prepared for all the selected teeth, for each patient the first tooth will be restored with chemically cured conventional GICs without any enhancement (M1 group). Meanwhile, the second tooth will be restored by chemically cured conventional GICs that enhanced with radiant heat (LED) (M2 group). functional and biological criteria of each restoration will be clinically evaluated at 4 time points

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
18

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 20, 2021

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 20, 2022

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 22, 2022

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

February 15, 2023

Completed
12 days until next milestone

First Posted

Study publicly available on registry

February 27, 2023

Completed
Last Updated

February 27, 2023

Status Verified

February 1, 2023

Enrollment Period

1 year

First QC Date

February 15, 2023

Last Update Submit

February 15, 2023

Conditions

Outcome Measures

Primary Outcomes (2)

  • Clinical performance of biological properties

    Clinical performance of biological properties according to FDI criteria

    12 months

  • Clinical performance of Functional properties

    Clinical performance of Functional properties according to FDI criteria

    12 months

Study Arms (2)

chemically cured conventional glass ionomer restorative (Ketac Universal Aplicap)

EXPERIMENTAL

For restoration of M1 group, capsule activation will be performed through loading of the KetacTM Universal AplicapTM GIC capsule into its activator keeping the applicator nozzle closed, using the ball of my hand to depress the activator lever firmly as far as it will go and hold it down for 2 to 4 seconds. Then the capsule will be mixed in a high frequency mixing device for 8 seconds. The mixed capsule will be immediately removed from the mixer and loaded into the AplicapTM Applier then application nozzle will be opened to extrude the mixture directly into the preparation as a single bulk within 1:40 minute. The preliminary contour will be done using a ball burnisher.

Other: KetacTM Universal AplicapTM

Ketac Universal Aplicap enhanced with light-emitting diode radiant heat

EXPERIMENTAL

Restoration of M2 group will be performed following the same steps which will be carried out for M1 group but the achieved restorations will be enhanced by light-emitting diode radiant heat for 60 seconds

Other: KetacTM Universal AplicapTM with light cure

Interventions

chemically cured conventional GICs

chemically cured conventional glass ionomer restorative (Ketac Universal Aplicap)

chemically cured conventional GICs with light curing enhancement

Ketac Universal Aplicap enhanced with light-emitting diode radiant heat

Eligibility Criteria

Age21 Years - 45 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Age group 21 - 45 years.
  • Both males and females will be included.
  • Ability to return for periodic follow-up (good general health).
  • Only co-operative patients.
  • Vital upper or lower carious posterior teeth.

You may not qualify if:

  • Teeth with any pathologic pulpal disease.
  • Teeth with previous restorations
  • Teeth with surface loss due to attrition, erosion, abrasion, or abfraction.
  • Patients with severe or chronic periodontitis.
  • Patients have allergy to the materials used in this trial. 6- Nonfunctioning teeth with no opposing dentition.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of dentistry, Suez Canal university

Ismailia, Egypt

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant lecturer operative dentistry department

Study Record Dates

First Submitted

February 15, 2023

First Posted

February 27, 2023

Study Start

February 20, 2021

Primary Completion

February 20, 2022

Study Completion

May 22, 2022

Last Updated

February 27, 2023

Record last verified: 2023-02

Data Sharing

IPD Sharing
Will not share

Locations